News from Zyme and the companies we work with.
Bio-Rad Expands Foresight Pro Prepacked Chromatography Columns with Nuvia Ion Exchange and Mixed-Mode Resins for Biomanufacturing
Extended Range of Process-Scale Columns Prepacked with CEX, AEX, CEX-HIC, and AEX-HIC Chromatography Resins Provides an Effective Solution for Purification of Biomolecules in Downstream Processing HERCULES, Calif.—September 01, 2026—Bio-Rad Laboratories, [...]
Carterra Enables Anthropic’s Autonomous AI Protein Design Study via its HT-SPR Binding Platforms
Salt Lake City, Utah, August 24, 2026: Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR) platforms for antibody and small molecule drug discovery, today highlighted the role of [...]
FairJourney Bio delivers antibody engineering for novel tumor-conditional IL-12 therapeutic approach that unlocks the potential of localized cytokine activation
Study in mAbs describes the first reported demonstration of a reversible trans-activation logic gate for tumor-conditional cytokine delivery FJBio engineered dual-specificity Fabs to meet model-defined affinity window through an end-to-end [...]
Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model
Investment in new premises in London reflects significant milestone in Company’s growth, following $20 million Series B financing Supports rapid scale-up and development of foundational AI imaging model, to improve [...]
Tagomics introduces LiquiPath, a first-in-class cfDNA-based blood test for multi-organ drug safety monitoring
Non-invasive cell-free DNA liquid biopsy platform for multi-organ monitoring of drug-safety across preclinical and clinical settings Early access programme now open for drug developers to shape future platform capabilities and [...]
SynGenSys introduces expanded CHO.SET synthetic promoter library for enhanced biomanufacturing
CHO.SET® 2.0 library of synthetic promoters provide tuneable expression of transgenes whilst maximising CHO cell productivity CHO.SET® promoters enable higher protein titres, reduced costs and shorter development timelines Sheffield, UK, [...]
CN Bio awarded Innovate UK grant to reduce animal use in pharmacokinetic studies
Grant funding delivered in partnership with the NC3Rs, in support of UK Government roadmap to reduce animal testing by 2030 Project to develop standardized workflow to more accurately predict drug [...]
Calla Lily Clinical Care selected to join Wellcome Leap’s $50M Focused Antibiotics Programme
Callavid intravaginal drug delivery platform selected to advance targeted UTI treatment as part of new programme addressing antibiotic-driven antimicrobial resistance London, UK, 11 August 2026: Calla Lily Clinical Care, a [...]
Broken String Biosciences launches BaseMap ABE to enable genome-wide off-target characterization in base editing therapeutic development
Extension of the INDUCE-seq platform to support adenine base editing (ABE) workflows Researchers invited to gain early access to platform and support ongoing product development Cambridge, UK, 10 August 2026 [...]
DNA Script and leading healthcare solutions provider awarded up to $26M by ARPA-H to advance cell-free DNA bioproduction
FLASH program, in collaboration with GE HealthCare, to support development of faster, distributed DNA manufacturing for next-generation therapies Paris, France, 04 August 2026: DNA Script, a pioneer in DNA synthesis [...]
Qureight closes $20 million Series B financing
Round led by Molten Ventures alongside existing investors Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension Investment will support Qureight’s next-generation AI-powered quantitative imaging platform to further [...]
Leerink Partners Report Names Carterra a Core Enabler of the $7B “Lab-in-the-Loop” Antibody Discovery Market
New research on AI-driven biologics discovery identifies Carterra's high-throughput SPR platforms as central to the Lab-in-the-Loop (LitL) workflow reshaping drug discovery, with Twist Bioscience and Adaptyv Bio pointing to surging [...]
